Do you provide ECM & Skin Ageing?
What ECM & Skin Ageing testing covers in the dermis
The dermal matrix is a network of collagen, elastic fibres, proteoglycans and glycoproteins made and renewed by fibroblasts. With age and sun exposure, synthesis slows, degradation by matrix metalloproteinases rises, sugars cross-link proteins and more cells become senescent. Each child service measures one of these processes.
Matrix synthesis assays
Collagen synthesis studies read procollagen type I secretion by ELISA or COL1A1 expression by qPCR in dermal fibroblasts. Elastin production tracks tropoelastin and elastic fibre deposition. Proteoglycan synthesis covers decorin, versican and hyaluronic acid with HAS gene expression. Structural protein synthesis groups fibronectin, laminin and related proteins, and fibroblast activation measures proliferation and migration in scratch assays.
Degradation, glycation and remodelling
MMP inhibition uses fluorogenic substrates, zymography or ELISA to follow collagenase and gelatinase activity, often after UV exposure. Anti-glycation activity measures the formation of advanced glycation end products in protein models or cells. Dermal matrix remodelling uses collagen gel contraction, and fibrosis-related matrix responses read TGF-beta and alpha-SMA.
Cell ageing and photo-ageing models
Senescence reduction counts SA-beta-galactosidase positive cells and p16 or p21 expression. Photo-ageing protection testing exposes cells or tissue to UVA or UVB and measures MMP release, oxidative markers and matrix loss. Keratinocyte proliferation covers epidermal renewal, and skin firmness testing measures mechanical properties on volunteers.
Controls, viability and histology in each report
Each study delivers a report with the model, concentrations, positive and negative controls, viability data, statistics and, where relevant, histology or immunostaining images.
Services in ECM & Skin Ageing
Planning an ECM & Skin Ageing study programme
Most anti-ageing actives are tested on more than one endpoint, so the order of studies matters as much as the choice.
Matching the assay to the ingredient
A signal peptide marketed for collagen boosting belongs in collagen and fibroblast assays. An antioxidant or sun-care active fits photo-ageing and MMP studies, where UV stress is part of the model. Sugar-related ageing claims call for anti-glycation testing, and cell-longevity positioning calls for senescence markers.
Moving from cells to tissue
Monolayer fibroblast assays are quick and suit dose finding. Once a dose is set, reconstructed full-thickness skin or ex vivo explants let you apply the formulated product topically and confirm the effect in a layered tissue with histology. That step gives you images for technical presentations.
Linking mechanism to visible results
Mechanism data supplies the ingredient-level evidence behind a finished product. The visible outcome is measured on volunteers in anti-ageing and wrinkle efficacy testing, and pairing the two gives a claim set that covers both the ingredient mechanism and the result on skin.
More in Skin Ageing Testing
Skin ageing, wrinkle and firmness efficacy testing measures lines, elasticity and texture on volunteers, and collagen and elastin activity in the lab.



